You would have found out by now if you interviewed this week. If you fit the “Lilly” profile the. You are in. If you have experience you are out. They have a profile.
This is bad practice if this is the case. Why not post what they really want on the job ad and not a bunch of ish they don't really care about. Companies and interviewers needs to get called out on if this is the case!!
I'm here to tell you there is hope for us. Higher ups actively recruiting two Amgen cgrp guys who have built this market and might leave Amgen for the right price. They will singlehandedly get customers to switch products with one phone call. We hope to recruit Nelson and Ross, we will be the market leader day 1.
Nelson Costa is a joke, he’s terrible. He was with Avanir for their migraine launch before he went to Amgen and the launch was a disaster. No KOL’s did anything for Nelson.
Good luck losers. Tear up your offers, and start learning to code. Not too late to get into computer science. https://www.reuters.com/article/us-amgen-pricing-migraine/amgens-new-migraine-drug-hits-insurance-hurdles-idUSKBN1KG0CT
Failure is the true mark of Lilly leadership. Nelson is poised for a long and rewarding career at Lilly.
I was Balt on Tuesday they said everyone would know by Friday but who knows ? I’ve received no contact since then no rejection or offer .
No, the patients get the drug from any pharmacy CVS ect and actually inject them self once a month patients do it at home, doctors will not have to buy this directly. Just prescribe it
Word is Neuro spec is adding a sales Director and we are considering an Amg guy, not Nelson. I have heard the other guys name floating around home office. Amg will get pounced by all the new entrants. Good luck all with the offers.
Are they looking for reps new to pharma or with experience? I have an interview coming up and just curious
When and where is your interview we thought all the interviews were done last week , Seems like they’re going to take a mix of experienced reps and new reps.
Amgen will not get pounced. Amgen has solidified their place. We're going to have the same problems here they had. There's enough demand out there. Lilly luanches terribly and the drug has more cv problems working on the ligand and not just blocking the specific cgrp receptor. We are going to get killed. and pcp aren't going to write. it's going to be hard
